Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stewart T Cole

Showing results (11-20 of 237) with videos related to

Pageof 24
Sort By:
Antimicrobial Agents and Chemotherapy|May 20, 2015
Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosisBenoit Lechartier, Stewart T Cole
Current Opinion in Microbiology|September 29, 2009
From functional genomics to systems (micro)biologyCarmen Buchrieser, Stewart T Cole
Current Opinion in Microbiology|August 9, 2011
New tuberculosis drugs on the horizonStewart T Cole, Giovanna Riccardi
Science (New York, N.Y.)|January 18, 2005
Microbiology. TB--a new target, a new drugStewart T Cole, Pedro M Alzari
Nature Reviews. Drug Discovery|May 1, 2013
Advances in the development of new tuberculosis drugs and treatment regimensAlimuddin Zumla, Payam Nahid, Stewart T Cole
Tuberculosis (Edinburgh, Scotland)|October 29, 2010
The MycoBrowser portal: a comprehensive and manually annotated resource for mycobacterial genomesAdamandia Kapopoulou, Jocelyne M Lew, Stewart T Cole
Antimicrobial Agents and Chemotherapy|March 5, 2014
Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosisRuben C Hartkoorn, Swapna Uplekar, Stewart T Cole
Nature Reviews. Microbiology|December 17, 2008
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulceransCaroline Demangel, Timothy P Stinear, Stewart T Cole
Cell Host & Microbe|May 21, 2009
Dissecting regulatory networks in host-pathogen interaction using chIP-on-chip technologyClaudia Sala, David C Grainger, Stewart T Cole
Plos Medicine|November 9, 2007
New approaches to filling the gap in tuberculosis drug discoveryMartina Casenghi, Stewart T Cole, Carl F Nathan
Pageof 24

Showing results (11-20 of 237) with videos related to

Sort By:
Pageof 24
Antimicrobial Agents and Chemotherapy|May 20, 2015
Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosisBenoit Lechartier, Stewart T Cole
Current Opinion in Microbiology|September 29, 2009
From functional genomics to systems (micro)biologyCarmen Buchrieser, Stewart T Cole
Current Opinion in Microbiology|August 9, 2011
New tuberculosis drugs on the horizonStewart T Cole, Giovanna Riccardi
Science (New York, N.Y.)|January 18, 2005
Microbiology. TB--a new target, a new drugStewart T Cole, Pedro M Alzari
Nature Reviews. Drug Discovery|May 1, 2013
Advances in the development of new tuberculosis drugs and treatment regimensAlimuddin Zumla, Payam Nahid, Stewart T Cole
Tuberculosis (Edinburgh, Scotland)|October 29, 2010
The MycoBrowser portal: a comprehensive and manually annotated resource for mycobacterial genomesAdamandia Kapopoulou, Jocelyne M Lew, Stewart T Cole
Antimicrobial Agents and Chemotherapy|March 5, 2014
Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosisRuben C Hartkoorn, Swapna Uplekar, Stewart T Cole
Nature Reviews. Microbiology|December 17, 2008
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulceransCaroline Demangel, Timothy P Stinear, Stewart T Cole
Cell Host & Microbe|May 21, 2009
Dissecting regulatory networks in host-pathogen interaction using chIP-on-chip technologyClaudia Sala, David C Grainger, Stewart T Cole
Plos Medicine|November 9, 2007
New approaches to filling the gap in tuberculosis drug discoveryMartina Casenghi, Stewart T Cole, Carl F Nathan
Pageof 24